BRIEF published on 01/14/2025 at 14:35, 1 year 10 months ago Quantum BioPharma Ltd. commence à négocier sur le marché en amont Biopharmacie Quantique Double Cotation Investisseurs Mondiaux Négoce En Amont Entreprise Biopharmaceutique
PRESS RELEASE published on 01/14/2025 at 14:30, 1 year 10 months ago Quantum Biopharma Ltd. Now Trading on Upstream Under QNTM Quantum BioPharma Ltd. dual lists on Upstream's global securities trading app, providing international investors streamlined access to Quantum shares. Details at https://www.quantumbiopharma.com/investors Investors Dual Listing Quantum BioPharma Upstream Global Securities Trading
BRIEF published on 01/07/2025 at 14:35, 1 year 10 months ago Quantum Biopharma Ltd. va s'inscrire en double sur le marché en amont Plateforme De Trading Biopharmacie Quantique Double Annonce Marché En Amont Investisseurs Mondiaux
BRIEF published on 01/07/2025 at 14:35, 1 year 10 months ago Quantum Biopharma Ltd. to Dual List on Upstream Market Dual Listing Global Investors Trading Platform Quantum BioPharma Upstream Market
PRESS RELEASE published on 01/07/2025 at 14:30, 1 year 10 months ago Quantum Biopharma Ltd. Approved to Dual List on Upstream Quantum BioPharma dual lists on Upstream for global trading on January 14th, expanding investor opportunity. Details on trading and shareholder instructions provided Dual Listing Quantum BioPharma Investor Opportunity Upstream Global Trading
BRIEF published on 12/21/2024 at 01:35, 1 year 10 months ago Quantum BioPharma conclut la deuxième tranche de son offre Biopharmacie Quantique Unités D'obligations NASDAQ:QNTM Deuxième Tranche Investissement Biopharmaceutique
BRIEF published on 12/21/2024 at 01:35, 1 year 10 months ago Quantum BioPharma Concludes Second Tranche of Offering Quantum BioPharma Debenture Units Second Tranche Biopharmaceutical Investment NASDAQ:QNTM
PRESS RELEASE published on 12/21/2024 at 01:30, 1 year 10 months ago Quantum Biopharma Announces Closing of Second Tranche Quantum BioPharma announces closing of Second Tranche of offering, issuing 500 Debenture Units for $500,000 to advance business model and working capital Working Capital Business Model Quantum BioPharma Debenture Units Second Tranche
BRIEF published on 12/20/2024 at 15:20, 1 year 10 months ago Quantum BioPharma Embraces Cryptocurrency for Treasury Diversification Financial Compliance Strategic Diversification Quantum BioPharma Bitcoin Treasury Cryptocurrency Investment
BRIEF published on 12/20/2024 at 15:20, 1 year 10 months ago Quantum BioPharma adopte la crypto-monnaie pour diversifier sa trésorerie Conformité Financière Diversification Stratégique Biopharmacie Quantique Trésor Bitcoin Investissement En Crypto-monnaie
Published on 11/18/2026 at 14:30, 31 minutes ago Boron One Announces Non-Binding Heads of Agreement with Multinational Manufacturing Company
Published on 11/18/2026 at 13:35, 1 hour 26 minutes ago ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
Published on 11/18/2026 at 13:30, 1 hour 31 minutes ago NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
Published on 11/18/2026 at 13:20, 1 hour 41 minutes ago Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
Published on 11/18/2026 at 13:00, 2 hours 1 minute ago Silver Storm to Attend the 121 Mining Investment Conference in London, UK
Published on 11/18/2026 at 14:30, 31 minutes ago Iute Strengthens Governance at Iute Bank to Support Next Stage of Growth in Ukraine
Published on 11/18/2026 at 14:25, 36 minutes ago Biocon's Pertuzumab Receives Marketing Authorization in EU, First Biosimilar Authorized Under EMA's New Tailored Clinical Approach
Published on 11/18/2026 at 14:05, 56 minutes ago TeleData Accelerates XGS-PON Service Rollout in Germany and Unifies its Network with Harmonic's cOS Broadband Platform
Published on 11/18/2026 at 14:05, 56 minutes ago mAbxience and OncoPrecision Announce Manufacturing and Investment Agreement for OncoPrecision's ADC Candidate ONC001
Published on 11/18/2026 at 07:45, 7 hours 16 minutes ago Successful pricing of US$ 10 billion of bonds as part of the financing of the PTC acquisition
Published on 11/18/2026 at 07:45, 7 hours 16 minutes ago Succès de l’émission obligataire de 10 milliards dollars américains dans le cadre du financement de l’acquisition de PTC